hero section gradient
15 handpicked stocks

Potential Bargains

These companies are trading below what experts believe they're truly worth. Our analysts have carefully selected stocks with significant upside potential, representing hidden opportunities for growth as they move toward their projected valuations.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Concise market capitalisation summary and investor key takeaways for the 'Potential Bargains' basket.

Key Takeaways for Investors:
  • Large-cap dominance implies likely lower volatility, more stable returns, and closer market-tracking than small-cap-heavy baskets.
  • Suitable as a core holding for steady exposure, not a speculative growth allocation.
  • Likely gradual, long-term appreciation rather than short-term explosive gains; manage expectations accordingly.
Total Market Cap
  • PMN: $23.69M

  • STRR: $6.89M

  • SVCO: $182.29M

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection captures the essence of value investing—buying quality assets at a discount to their intrinsic value. We've identified companies where there's a substantial gap between current price and analyst targets, suggesting significant growth potential as the market eventually recognizes their true worth.

2

What You Need to Know

These stocks come from diverse sectors including technology, biotechnology, and cyclical industries that may be temporarily out of favor. While they offer higher-reward opportunities, they can also carry more risk as the market may take time to recognize their potential value.

3

Why These Stocks

Each company was selected based on strong analyst "Buy" ratings and a substantial difference between current trading price and future valuation estimates. They represent businesses with strong fundamentals that financial experts believe the market has overlooked or undervalued.

Why You'll Want to Watch These Stocks

💰

Hidden Value Waiting to Be Discovered

These companies are flying under the radar with strong fundamentals that the market hasn't fully recognized yet. Getting in now could mean significant returns when others finally catch on.

📈

Potential for Dramatic Price Corrections

When undervalued stocks finally get the attention they deserve, price movements can happen quickly. Analysts believe these companies could see substantial growth as they move toward their true valuations.

🧠

Expert-Backed Opportunities

These aren't random picks—each stock has been identified by market professionals as trading below its intrinsic value, giving you confidence that you're investing based on expert analysis.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Airbus has cut its delivery targets after discovering a significant fuselage flaw in its A320 aircraft, causing production delays and requiring widespread inspections. This situation could create a significant opening for its main competitor, Boeing, and other aerospace manufacturers to capture market share from airlines seeking to avoid delivery uncertainties.

Cargo Capacity Crisis: Which Stocks May Benefit Most?

Cargo Capacity Crisis: Which Stocks May Benefit Most?

The crash of a UPS cargo plane has led to the grounding of an entire class of aging aircraft across the logistics industry. This creates a potential investment opportunity in competing cargo carriers and aircraft manufacturers poised to fill the resulting gap in shipping capacity.

UK-US Pharma Trade Deal | Tariff-Free Market Access

UK-US Pharma Trade Deal | Tariff-Free Market Access

A new trade deal eliminates tariffs on pharmaceuticals between the UK and the US, strengthening transatlantic trade. This creates a powerful tailwind for pharmaceutical companies in both countries, potentially boosting exports, innovation, and profitability.

Frequently Asked Questions